Studies have also revealed that BRCA1-deficient cancers are associated with greater numbers of tumor-infiltrating lymphocytes (TIL) than other cancers and with increased expression of immunomodulatory genes, including PDCD1 (PD-1), PD-L1, and CTLA420–22. This evidence concerns the gene PDCD1 and neoplasm.